Anixa Biosciences's total assets for Q3 2025 were $17.65M, an increase of 3.97% from the previous quarter. ANIX total liabilities were $2.24M for the fiscal quarter, a 8.16% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.